Intersection of EP and HF: Making GDMT Happen: Operationalizing HF Risk Factor Modification and Uptitration in EP Centered Care Part 2-Intersection of EP and HF: Making GDMT Happen: Operationalizing HF Risk Factor Modification and Uptitration in EP Centered Care Part 2 Video

Intersection of EP and HF: Making GDMT Happen: Operationalizing HF Risk Factor Modification and Uptitration in EP Centered Care Part 2 Video

Back to course

Video Transcription

Video Summary

Carolyn Lam argues that atrial fibrillation and heart failure—especially HFpEF—are often the same patient with overlapping symptoms and shared causes. She reviews guidelines showing anticoagulation first, limited rhythm-control recommendations, and strong evidence for ablation mainly in HFrEF, but little data in HFpEF. She emphasizes rapid initiation of foundational heart failure therapy, especially SGLT2 inhibitors and MRAs, which can also reduce AF. She highlights obesity/inflammation as a common “soil” and notes GLP-1 receptor agonists may help HFpEF with obesity. Her message: EP and heart failure teams should bridge approaches and treat both rhythm and substrate.

Keywords

atrial fibrillation

heart failure with preserved ejection fraction

anticoagulation

SGLT2 inhibitors

catheter ablation